LENCYA



Trademark Coverage

No Class Specified

Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, antibacterials, antivirals, antibotics, and antifungals

Owner

Novartis AG

Business in Basel, CH

Owns 5325 trademarks

Timeline
  • Dec 28
    2012
    Cancelled SEC 8 (6 Yr)
  • Jun 25
    2009
    TEAS Change Of Correspondence Received
  • May 23
    2006
    Registered Principal Register
  • Apr 06
    2006
    1(B) Basis Deleted; Proceed To Registration
  • Mar 06
    2006
    Notice Of Allowance Cancelled
  • Sep 14
    2005
    TEAS Delete 1(B) Basis Received
  • Sep 06
    2005
    NOA Mailed SOU Required From Applicant
  • Jun 14
    2005
    Published For Opposition
  • May 25
    2005
    Notice Of Publication
  • Mar 02
    2005
    Law Office Publication Review Completed
  • Feb 18
    2005
    Assigned To LIE
  • Feb 11
    2005
    Approved For PUB Principal Register
  • Dec 02
    2004
    Amendment From Applicant Entered
  • Nov 17
    2004
    Correspondence Received In Law Office
  • Nov 17
    2004
    Paper Received
  • Nov 15
    2004
    Paper Received
  • Nov 16
    2004
    TEAS Change Of Correspondence Received
  • Sep 22
    2004
    Non Final Action E Mailed
  • Sep 22
    2004
    Non Final Action Written
  • Sep 21
    2004
    Assigned To Examiner
  • Mar 23
    2004
    New Application Entered In TRAM